Table 5 |
||
|
Potential differences between type 2 diabetes and CHF with regards to uncertainty, and how they might influence CAS characteristic effectiveness |
||
|
CAS characteristic |
type 2 diabetes |
CHF |
|
|
||
|
Learning |
Treatment is nuanced and complex, making efforts to improve outcomes through learning more difficult. |
Less uncertainty in treatment guidelines allows more prescriptive, algorithmic approaches to management that may be more easily learned. |
|
|
||
|
Interconnections |
Greater degree of uncertainty in terms of symptoms and management, leading to greater reliance on interconnections to manage disease. |
Lesser degree of uncertainty in terms of symptoms and management may lead interventions focused on interconnections less effective. |
|
|
||
|
Self-organization |
Greater uncertainty in management and symptoms of exacerbation may make efforts to self-organize more difficult. |
Less uncertainty regarding management and symptoms of exacerbation may make efforts to self-organize more effective. |
|
|
||
|
Co-evolution |
Course and symptoms evolve over time in unique trajectory. |
Course and symptoms evolve over time in unique trajectory. |
|
|
||
|
Leykum et al. Implementation Science 2010 5:66 doi:10.1186/1748-5908-5-66 |
||